Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation-Reference-Cited by-同舟云学术

Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation

Published:2022-03 Issue:3 Volume:164 Page:514-521
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Xia Yue Yin,Gronwald Jacek,Karlan Beth,Lubinski Jan,McCuaig Jeanna M.,Brooks Jennifer,Moller Pal,Eisen Andrea,Sun Sophie,Senter Leigha,Bordeleau Louise,Neuhausen Susan L.,Singer Christian F.,Tung Nadine,Foulkes William D.,Sun Ping,Narod Steven A.,Kotsopoulos Joanne,Yerushalmi Rinat,Fruscio Robert,Rastelli Antonella,Zovato Stefania,Hyder Zerin,Huzarski Tomasz,Cybulski Cezary,Sweet Kevin,Wood Marie,McKinnon Wendy,Elser Christine,Pal Tuya,Wiesner Georgia,Friedman Eitan,Meschino Wendy,Snyder Carrie,Metcalfe Kelly,Poll Aletta,Gojska Nicole,Warner Ellen,Kim Raymond H.,Rosen Barry,Demsky Rochelle,Ainsworth Peter,Panabaker Karen,Steele Linda,Saal Howard,Serfas Kim,Panchal Seema,Cullinane Carey A.,Reilly Robert E.,Blum Joanne L.,Kwong Ava,Cybulski Cezary,Rayson Daniel,Isaacs Claudine,Ramón y Cajal Teresa,Dungan Jeffrey,Cohen Stephanie

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

2. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations;Rebbeck;N. Engl. J. Med.,2002

3. Hereditary ovarian cancer clinical study group, Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation;Finch;JAMA,2006

4. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers;Marchetti;BMC Womens Health,2014

5. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls;Lancet,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer;Journal of Cancer Research and Clinical Oncology;2024-09-11

2. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

3. Global epidemiology of epithelial ovarian cancer;Nature Reviews Clinical Oncology;2024-03-28

4. Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis;Cancer Epidemiology, Biomarkers & Prevention;2024-02-01

5. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis;BMC Genomic Data;2024-01-31